相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格:
T25
Caco2/Caco-2人结直肠腺癌细胞Cell line name Caco-2
Synonyms CaCo-2; CACO-2; Caco 2; CACO 2; CACO2; CaCo2; CaCO2; Caco2; Caco-2/ATCC; Caco-II
Accession CVCL_0025
Resource Identification Initiative To cite this cell line use: Caco-2 (RRID:CVCL_0025)
Comments Part of: AstraZeneca Colorectal cell line (AZCL) panel.
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: ENCODE project common cell types; tier 3.
Part of: MD Anderson Cell Lines Project.
Population: Caucasian.
Virology: Highly susceptible to infection by SARS coronavirus (SARS-CoV) (PubMed=15316659; PubMed=15731278).
Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257; PubMed=34339474).
Doubling time: 51.41 hours (PubMed=25944804); 3-4 days (ATCC=HTB-37); ~60-70 hours (CLS=300137); ~80 hours (DSMZ=ACC-169); ~32 hours (PBCF).
Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746).
Omics: CTCF ChIP-seq epigenome analysis.
Omics: H3K27me3 ChIP-seq epigenome analysis.
Omics: H3K36me3 ChIP-seq epigenome analysis.
Omics: H3K4me3 ChIP-seq epigenome analysis.
Omics: Deep antibody staining analysis.
Omics: Deep exome analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: miRNA expression profiling.
Omics: N-glycan profiling.
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Omics: Transcriptome analysis by serial analysis of gene expression (SAGE).
Derived from site: In situ; Colon; UBERON=UBERON_0001155.
PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)
PubMed=3349466
Chantret I., Barbat A., Dussaulx E., Brattain M.G., Zweibaum A.
Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.
Cancer Res. 48:1936-1942(1988)
PubMed=2914637; DOI=10.1016/0016-5085(89)90897-4
Hidalgo I.J., Raub T.J., Borchardt R.T.
Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.
Gastroenterology 96:736-749(1989)
PubMed=7764660; DOI=10.1007/BF00749813
Hashimoto K., Shimizu M.
Epithelial properties of human intestinal Caco-2 cells cultured in a serum-free medium.
Cytotechnology 13:175-184(1993)
PubMed=8253353; DOI=10.1016/0016-5085(93)91076-t
Chastre E., Empereur S., Di Gioia Y., El Mahdani N., Mareel M.M., Vleminckx K.L., Van Roy F.M., Bex V., Emami S., Spandidos D.A., Gespach C.
Neoplastic progression of human and rat intestinal cell lines after transfer of the ras and polyoma middle T oncogenes.
Gastroenterology 105:1776-1789(1993)
PubMed=8508948; DOI=10.1111/j.1432-0436.1993.tb00645.x
de Bruine A.P., de Vries J.E., Dinjens W.N.M., Moerkerk P.T.M., van der Linden E.P.M., Pijls M.M.J., ten Kate J., Bosman F.T.
Human Caco-2 cells transfected with c-Ha-Ras as a model for endocrine differentiation in the large intestine.
Differentiation 53:51-60(1993)
PubMed=9294210; DOI=10.1073/pnas.94.19.10330; PMCID=PMC23362
Ilyas M., Tomlinson I.P.M., Rowan A.J., Pignatelli M., Bodmer W.F.
Beta-catenin mutations in cell lines established from human colorectal cancers.
Proc. Natl. Acad. Sci. U.S.A. 94:10330-10334(1997)
PubMed=10092214; DOI=10.1002/(SICI)1097-4652(199812)177:4<618::AID-JCP12>3.0.CO;2-R
Levy P., Robin H., Kornprobst M., Capeau J., Cherqui G.
Enterocytic differentiation of the human Caco-2 cell line correlates with alterations in integrin signaling.
J. Cell. Physiol. 177:618-627(1998)
PubMed=10612807; DOI=10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; PMCID=PMC4721570
Ghadimi B.M., Sackett D.L., Difilippantonio M.J., Schrock E., Neumann T., Jauho A., Auer G., Ried T.
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations.
Genes Chromosomes Cancer 27:183-190(2000)
PubMed=10737795; DOI=10.1073/pnas.97.7.3352; PMCID=PMC16243
Rowan A.J., Lamlum H., Ilyas M., Wheeler J., Straub J., Papadopoulou A., Bicknell D.C., Bodmer W.F., Tomlinson I.P.M.
APC mutations in sporadic colorectal tumors: a mutational 'hotspot' and interdependence of the 'two hits'.
Proc. Natl. Acad. Sci. U.S.A. 97:3352-3357(2000)
PubMed=11414198; DOI=10.1007/s004320000207
Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.-J.
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
J. Cancer Res. Clin. Oncol. 127:375-386(2001)
PubMed=11416159; DOI=10.1073/pnas.121616198; PMCID=PMC35459
Masters J.R.W., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G., Packer P., Toji L.H., Ohno T., Tanabe H., Arlett C.F., Kelland L.R., Harrison M., Virmani A.K., Ward T.H., Ayres K.L., Debenham P.G.
Short tandem repeat profiling provides an international reference standard for human cell lines.
Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001)
PubMed=11668190; DOI=10.1177/002215540104901105
Quentmeier H., Osborn M., Reinhardt J., Zaborski M., Drexler H.G.
Immunocytochemical analysis of cell lines derived from solid tumors.
J. Histochem. Cytochem. 49:1369-1378(2001)
PubMed=12584437; DOI=10.1159/000068544
Melcher R., Koehler S., Steinlein C., Schmid M., Mueller C.R., Luehrs H., Menzel T., Scheppach W., Moerk H., Scheurlen M., Koehrle J., Al-Taie O.
Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway.
Cytogenet. Genome Res. 98:22-28(2002)
PubMed=14599474; DOI=10.1016/S0887-2333(03)00095-X
Ranaldi G., Consalvo R., Sambuy Y., Scarino M.L.
Permeability characteristics of parental and clonal human intestinal Caco-2 cell lines differentiated in serum-supplemented and serum-free media.
Toxicol. In Vitro 17:761-767(2003)
PubMed=15316659; DOI=10.1007/s00018-004-4222-9; PMCID=PMC7079841
Cinatl J. Jr., Hoever G., Morgenstern B., Preiser W., Vogel J.-U., Hofmann W.-K., Bauer G., Michaelis M., Rabenau H.F., Doerr H.-W.
Infection of cultured intestinal epithelial cells wit
Cell. Mol. Life Sci. 61:2100-2112(2004)
PubMed=15731278; DOI=10.1128/JVI.79.6.3846-3850.2005; PMCID=PMC1075706
Mossel E.C., Huang C., Narayanan K., Makino S., Tesh R.B., Peters C.J.
Exogenous ACE2 expression allows refractory cell lines to support se replication.
J. Virol. 79:3846-3850(2005)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验*发表【中文论文】请标注:由上海酶研生物科技有限公司提供;
*发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.
啊。既要消化到容易吹打下来,又不能太过,一吹就整片脱落,要单个单个地往下掉。所以我才要分批分次地加胰酶消化就是为了保证不同生长状态贴壁程度的细胞能够都维持在好的受力点分散开。这个是很重要的一点。尤其是对于某些细胞这一点就是他活去死的致命点。像Caco-2细胞就是如此。 另外关于传代很重要一点就是一定不能等到细胞长满的时候才去消化传代。要在细胞长到70%左右的时候就要传代了,一旦发现细胞生长中已经有叠层生长的时候就要立即进行消化传代。不能再拖了。 6.关于换液传代时候洗瓶的问题。 这个发现
药物吸收评价(Caco-2细胞模型模拟肠道屏障药物吸收)、血脑屏障穿透性检测(筛选可透过血脑屏障的靶向药物)、药物转运机制研究(探究药物主动转运、被动扩散规律)、新药渗透性与生物利用度前期筛选。 操作要点:需持续培养7–14天,通过检测跨膜电阻值(TEER)确认屏障完整性,方可开展药物转运实验,保证实验数据精准可靠。 (五)屏障功能完整性检测实验 适配规格:0.4μm孔径PET膜小室,适配各类屏障细胞模型。 实验原理:利用小室双层腔体结构,培养上皮、内皮细胞形成致密单层屏障,通过检测跨膜电阻、荧光染料渗漏
【旧贴整理】PCR版2006-06-16至08-17的无人应助帖
====================【求助】如何提乳酸杆菌和Caco-2细胞的RNA作者:yangfangisok====================【求助】请问两个引物的退货温度相差近20度怎么办?作者:核力量波音====================【求助】大肠杆菌基因组DNA电泳结果作者:bingyu810802====================【求助】只有二次PCR才有结果作者:mlk720====================【求助】我的RT-PCR后PCR结果怎么解释?作者:绿葡萄
技术资料





![【ATCC来源】NCTC clone 929 [L-929]、NCTC clone 929 [L cell, L-929]细胞、NCTC clone 929 [L cell, L-929]细胞、NCTC clone 929 [L cell, L-929]NCTC clone 929 [L cell, L-929][小鼠成纤维细胞]](https://img1.dxycdn.com/2021/0721/054/1466071650690953943-14.jpg!wh200)


